PRGO Q1 2024 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-8.4% YoY

Gross Profit

$358M33.1% margin

Operating Income

-$55M-5.1% margin

Net Income

$2M0.2% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-6.5%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$27M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$10.6B

Total Liabilities

$6.0B

Stockholders' Equity

$4.7B

Cash & Equivalents

$652M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.2B	-8.4%
Gross Profit	$358M	$414M	-13.6%
Operating Income	-$55M	$49M	-213.8%
Net Income	$2M	-$3M	+166.7%

Revenue Segments

Consumer Self-Care Americas

$644M60%

Consumer Self-Care International

$438M40%

Geographic Segments

UNITED STATES

$632M58%

Europe

$420M39%

Other Geographical Areas

$30M3%

IRELAND

$4M0%